Optimal Duration of Follow-up for Assessing Antimalarial Efficacy in Pregnancy: A Retrospective Analysis of a Cohort Followed Up Until Delivery on the Thailand–Myanmar Border

BACKGROUND: Follow-up for 28–42 days is recommended by the World Health Organization to assess antimalarial drug efficacy for nonpregnant populations. This study aimed to determine the optimal duration for pregnant women, as no specific guidance currently exists. METHODS: The distributions of time t...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Makoto, Mansoor, Rashid, Wiladphaingern, Jacher, Paw, Moo Kho, Pimanpanarak, Mupawjay, Proux, Stephane, Guérin, Philippe J, White, Nicholas J, Nosten, François, McGready, Rose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602886/
https://www.ncbi.nlm.nih.gov/pubmed/31281861
http://dx.doi.org/10.1093/ofid/ofz264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602886/
https://www.ncbi.nlm.nih.gov/pubmed/31281861
http://dx.doi.org/10.1093/ofid/ofz264

Ejemplares similares